logo
Sign in

PRVCF Stock Price, Chart, Stats & News

PreveCeutical Medical Inc.
Save

PreveCeutical Medical Inc. (PRVCF) does not currently pay a dividend.

8.73M
Market cap
Current P/E
Forward P/E

PRVCF chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Biotechnology
Industry

Vancouver, Canada-based PreveCeutical Medical Inc. operates as a health sciences company, focusing on the creation of both preventative and curative treatments derived from organic and nature-identical substances. The company's innovative pipeline includes a cannabinoid Sol-Gel Delivery system designed for nose-to-brain administration, offering potential relief for ailments such as pain, inflammation, seizures, and various neurological disorders. Other key initiatives involve the BSV Peptide Program, aimed at halting cancer progression; a non-addictive analgesic for effective pain management; and a Dual Gene Therapy addressing type 2 diabetes and obesity.

Similar securities

Based on sector and market capitalization

Report issue